Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kienast

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1995
Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic diseaseT Padró, J J Emeis, M Steins, et al.
Blood|March 1, 1987
Sodium fluoride mimics effects of both agonists and antagonists on intact human platelets by simultaneous modulation of phospholipase C and adenylate cyclase activityJ Kienast, J Arnout, G Pfliegler, et al.
The Journal of Infectious Diseases|September 18, 1997
Reciprocal changes in circulating interleukin-6 and its soluble receptor during evolving sepsis in leukocytopenic patientsH Ostermann, K Kratz-Albers, R M Mesters, et al.
The American Journal of Cardiology|August 1, 1996
Considerations about plasma fibrinogen concentration and the cardiovascular risk: combined evidence from the GRIPS and ECAT studies. Goettingen Risk Incidence and Prevalence Study. European Concerted Action on Thrombosis and DisabilitiesP Cremer, D Nagel, D Seidel, et al.
Critical Care Medicine|July 22, 1998
Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndromeM G Kiehl, H Ostermann, M Thomas, et al.
British Journal of Haematology|October 1, 1994
Cytokine response to infection in patients with acute myelogenous leukaemia following intensive chemotherapyH Ostermann, M Rothenburger, R M Mesters, et al.
Neurological Research|December 22, 1999
Tissue plasminogen activator and plasminogen activator inhibitor in patients with acute ischemic stroke: relation to stroke etiologyP Zunker, A Schick, T Padró, et al.
American Heart Journal|June 1, 1993
Relation of fibrinogen to presence and severity of coronary artery disease is independent of other coexisting heart disease. The ECAT Angina Pectoris Study GroupI Bolibar, J Kienast, S G Thompson, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1995
Markers of coagulation activation for evaluation of the antithrombotic efficacy of heparin: a prospective study in acute deep venous thrombosisR M Mesters, T Mikoteit, M Schiller, et al.
Klinische Wochenschrift|July 3, 1989
[Anti-phospholipid antibody with recurrent venous thromboembolism and severe autoimmune thrombocytopenia]J Kienast, H Ostermann, W Stenzinger, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1995
Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic diseaseT Padró, J J Emeis, M Steins, et al.
Blood|March 1, 1987
Sodium fluoride mimics effects of both agonists and antagonists on intact human platelets by simultaneous modulation of phospholipase C and adenylate cyclase activityJ Kienast, J Arnout, G Pfliegler, et al.
The Journal of Infectious Diseases|September 18, 1997
Reciprocal changes in circulating interleukin-6 and its soluble receptor during evolving sepsis in leukocytopenic patientsH Ostermann, K Kratz-Albers, R M Mesters, et al.
The American Journal of Cardiology|August 1, 1996
Considerations about plasma fibrinogen concentration and the cardiovascular risk: combined evidence from the GRIPS and ECAT studies. Goettingen Risk Incidence and Prevalence Study. European Concerted Action on Thrombosis and DisabilitiesP Cremer, D Nagel, D Seidel, et al.
Critical Care Medicine|July 22, 1998
Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndromeM G Kiehl, H Ostermann, M Thomas, et al.
British Journal of Haematology|October 1, 1994
Cytokine response to infection in patients with acute myelogenous leukaemia following intensive chemotherapyH Ostermann, M Rothenburger, R M Mesters, et al.
Neurological Research|December 22, 1999
Tissue plasminogen activator and plasminogen activator inhibitor in patients with acute ischemic stroke: relation to stroke etiologyP Zunker, A Schick, T Padró, et al.
American Heart Journal|June 1, 1993
Relation of fibrinogen to presence and severity of coronary artery disease is independent of other coexisting heart disease. The ECAT Angina Pectoris Study GroupI Bolibar, J Kienast, S G Thompson, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1995
Markers of coagulation activation for evaluation of the antithrombotic efficacy of heparin: a prospective study in acute deep venous thrombosisR M Mesters, T Mikoteit, M Schiller, et al.
Klinische Wochenschrift|July 3, 1989
[Anti-phospholipid antibody with recurrent venous thromboembolism and severe autoimmune thrombocytopenia]J Kienast, H Ostermann, W Stenzinger, et al.
Pageof 9